Results from secondary analysis of 2 randomised trials.

Correct diagnosis has implications for treatment and prognosis.

Women with PCOS may benefit from increased cancer surveillance.

Less than 2% of women adhere to 3 critical components for risk reduction.

Findings underscore recommendations to limit use to the shortest time possible.

A systematic review and meta-analysis.

TherapeuticsMD expects Bijuva to be available in the US in the second quarter of 2019.

Endothelial and vascular dysfunction may be a common mechanism in dementia risk.

Fertility status as a marker that manifests well before a disease might be an opening for risk reduction.

Women's Health Initiative study involved >61,000 postmenopausal women.

Association did not extend to premenopausal malignancy.

First trial of a bisphosphonate for osteopenia, a precursor to osteoporosis.

Clothing sizes offer an objective standard as a proxy to report overweight/obesity.

Study suggests chemotherapy is a factor for self-reported menopause within 1 year of diagnosis.